Hospitalization for diseases attributable to human papillomavirus in the Veneto Region (North-East Italy)

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Baldo, Vincenzo ^a   Cocchio, Silvia ^a   Buja, Alessandra ^a   Baldovin, Tatjana ^a   Furlan, Patrizia ^a   Bertoncello, Chiara ^a   Saia, Mario ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b EuroHealth Net   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANUS CANCER; ARTICLE; COHORT ANALYSIS; CONDYLOMA ACUMINATUM; DISEASE ASSOCIATION; FEMALE; GENITAL TRACT CANCER; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CANCER; PAPILLOMAVIRUS INFECTION; RETROSPECTIVE STUDY; TREND STUDY;

ADOLESCENT; ADULT; FEMALE; HOSPITALIZATION; HUMANS; ITALY; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84884937597     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-462     Document Type: Article

References (27)

1. Gewirtzman A, Bobrick L, Conner K, Tyring SK. Epidemiology of Sexually Transmitted Infections. Sexually Transmitted Infections and Sexually Transmitted Diseases 2011, 13-34. New York: Springer, Gross G, Tyring SK.
2. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, Markowitz LE. Prevalence of genital human papillomavirus among females in the United States, the National Health and Nutrition Examination Survey, 2003-2006. J Infect Dis 2011, 204:566-573. 10.1093/infdis/jir341, 21791659.
3. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, Graubard BI, Chaturvedi AK. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012, 307:693-703. 10.1001/jama.2012.101, 22282321.
4. Forman D, De Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S. Global burden of human papillomavirus and related diseases. Vaccine 2012, 30(Suppl 5):F12-F23.
5. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907. 10.1016/S0140-6736(07)61416-0, 17826171.
6. World Health Organization Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007, 90:1-689. World Health Organization.
7. De Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012, 13:607-615. 10.1016/S1470-2045(12)70137-7, 22575588.
8. Giuliano AR, Tortolero-Luna G, Ferrer E, Burchell AN, De Sanjose S, Kruger Kjaer S, Muñoz N, Schiffman M, Bosch FX. Epidemiology of Human Papillomavirus Infection in men, cancers other than cervical and benign conditions. Vaccine 2008, 26(Suppl 10):K17-K28.
9. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14:467-475. 10.1158/1055-9965.EPI-04-0551, 15734974.
10. Dunne EF, Markowitz LE. Genital human papillomavirus infection. Clin Infect Dis 2006, 43:624-629. 10.1086/505982, 16886157.
11. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis 2003, 36:1397-1403. 10.1086/375074, 12766834.
12. Gil-Prieto R, Ester PV, Alvaro-Meca A, Rodríguez MS, De Miguel AG. The burden of hospitalizations for anus and penis neoplasm in Spain (1997-2008). Vaccin Immunother 2012, 8:201-207.
13. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000, 19:335-351. 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z, 10649300.
14. Garante per la protezione dei dati personali Autorizzazione generale al trattamento dei dati personali effettuato per scopi di ricerca scientifica - 1° marzo 2012. Gazzetta Ufficiale della Repubblica Italiana 2012, 72:47-52. Garante per la protezione dei dati personali.
15. Boehmer TK, Patnaik JL, Burnite SJ, Ghosh TS, Gershman K, Vogt RL. Use of hospital discharge data to evaluate notifiable disease reporting to Colorado's electronic disease reporting system. Public Health Rep 2011, 126:100-106. 3072908, 21563717.
16. Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J 2006, 12:5.
17. Monsonego J. Genital infection with HPV in men: research into practice. Lancet 2011, 377:881-883. 10.1016/S0140-6736(11)60277-8, 21367447.
18. Pirotta MV, Stein AN, Fairley CK, Morrow A, Conway EL, Chuah J, McCloskey J, McNulty A, Waddell R, Carter R, Garland S. Patterns of treatment of external genital warts in Australian sexual health clinics. Sex Transm Dis 2009, 36:375-379. 10.1097/OLQ.0b013e3181971e4e, 19556931.
19. Langley P, White D, Drake S. Patterns of treatment and resource utilization in the treatment of external genital warts in England and Wales. Int J STD AIDS 2004, 15:473-478. 10.1258/0956462041211199, 15228733.
20. Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, Liaw KL, Nygård J, Nygård M. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007, 196:1447-1454. 10.1086/522863, 18008222.
21. Giorgi Rossi P, Esposito G, Brezzi S, Brachini A, Raggi P, Federici A. Estimation of Pap test coverage in an area with an organised screening program: challenges for survey methods. BMC Health Serv Res 2006, 6:36. 10.1186/1472-6963-6-36, 1435881, 16545125.
22. Delibera della Giunta Regionale n.734 del 20 marzo 2007 Prestazioni di chemioterapia e radioterapia. Bollettino Ufficiale della Regione Veneto 2007, 37:106-109. Delibera della Giunta Regionale n.734 del 20 marzo 2007.
23. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003, 157:218-226. 10.1093/aje/kwf180, 12543621.
24. ZurHausen H. The search for infectious causes of human cancers: where and why. Virology 2009, 392:1-10. 10.1016/j.virol.2009.06.001, 19720205.
25. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, Chang YH, Ferris D, Rouleau D, Bryan J, Marshall JB, Vuocolo S, Barr E, Radley D, Haupt RM, Guris D. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. N Engl J Med 2011, 364:401-411. 10.1056/NEJMoa0909537, 3495065, 21288094.
26. Giambi C. Stato di avanzamento della campagna vaccinale per l'HPV:dati di copertura vaccinale al 30/06/2012 - Rapporto Semestrale. http://www.epicentro.iss.it/problemi/hpv/pdf/Aggiornamento_HPV_30062012_validato.pdf.
27. Hartwig S, Syrjänen S, Dominiak-Felden G, Brotons M, Castellsagué X. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012, 12:30. 10.1186/1471-2407-12-30, 3293758, 22260541.